ResMed counsel Rider has 1,944 shares withheld for tax

Available on EDGAR 11/13/2026 - 06:07 AM EST Accepted by SEC EDGAR 11/13/2026 - 06:03 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

ResMed Inc. Global General Counsel Michael J. Rider reported four direct dispositions of common stock to the issuer for tax withholding on restricted stock unit vesting on November 11, 2026. The transactions totaled 1,944 shares, each reported at $234.11 per share. They related to restricted stock unit grants dated November 20, 2025; November 20, 2024; November 16, 2023; and November 16, 2022.

Insider Trade Summary

Tax Withholding: 1,943.5 shares

Tax Withholding 4 txns

Insider Rider Michael J

Role Global General Counsel

Type	Security	Shares	Price	Value
Tax Withholding	ResMed Common Stock F1	547.469	$234.11	$128K
Tax Withholding	ResMed Common Stock F2	498.624	$234.11	$117K
Tax Withholding	ResMed Common Stock F3	724.414	$234.11	$170K
Tax Withholding	ResMed Common Stock F4, F5	172.993	$234.11	$40K

Holdings After Transaction: ResMed Common Stock — 10,417 shares (Direct)

Footnotes (5)

1. F1. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.
2. F2. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.
3. F3. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
4. F4. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
5. F5. Includes 41.7624 shares of Resmed stock purchased on Oct 30, 2026 through the Resmed Employee Stock Purchase Plan.

Key Figures

Shares disposed for tax withholding: 1,944 shares Reported per-share price: $234.11 per share

2 metrics

Shares disposed for tax withholding 1,944 shares Four direct dispositions on November 11, 2026; rounded to the nearest whole share.

Reported per-share price $234.11 per share Reported for each of the four dispositions on November 11, 2026.

Key Terms

Restricted Stock Units, Resmed Employee Stock Purchase Plan

2 terms

Restricted Stock Units financial

"tax withholding on vesting of Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Resmed Employee Stock Purchase Plan financial

"through the Resmed Employee Stock Purchase Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RMD shares did the global general counsel report for tax withholding?

ResMed Global General Counsel Michael J. Rider reported four direct dispositions totaling 1,944 shares on November 11, 2026, each reported at $234.11 per share.

Which RMD restricted stock unit grants were linked to the November 2026 tax withholding?

ResMed Global General Counsel Michael J. Rider reported withholding on vesting of restricted stock units granted November 20, 2025; November 20, 2024; November 16, 2023; and November 16, 2022.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rider Michael J

(Last) (First) (Middle)

9001 SPECTRUM CENTER BLVD

(Street)

SAN DIEGO CALIFORNIA 92123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
ResMed Common Stock	11/11/2026		F(1)		547.469	D	$234.11	11,813	D
ResMed Common Stock	11/11/2026		F(2)		498.624	D	$234.11	11,314	D
ResMed Common Stock	11/11/2026		F(3)		724.414	D	$234.11	10,590	D
ResMed Common Stock	11/11/2026		F(4)		172.993	D	$234.11	10,417(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.

2. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.

3. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.

4. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.

5. Includes 41.7624 shares of Resmed stock purchased on Oct 30, 2026 through the Resmed Employee Stock Purchase Plan.

	/s/ Michael J. Rider, Global General Counsel and Secretary	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)